Concepedia

Publication | Open Access

An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

148

Citations

19

References

2008

Year

Abstract

Our 72-gene signature is closely associated with recurrence-free and overall survival in early-stage NSCLC patients and may become a tool for patient selection for adjuvant therapy.

References

YearCitations

Page 1